In the matched population, those who carried at least 1 minor allele of MTRR rs1801394 showed a significantly increased risk of CRC in the dominant model (OR, 1.43; 95% CI, 1.12 to 1.83). This evidence concerns the gene MTRR and colorectal carcinoma.